Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Bokf Na

Bokf Na decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.3% in the fourth quarter, Holdings Channel reports. The firm owned 22,081 shares of the medical equipment provider’s stock after selling 3,385 shares during the period. Bokf Na’s holdings in Intuitive Surgical were worth $12,089,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Principal Financial Group Inc. raised its position in shares of Intuitive Surgical by 1.5% in the 3rd quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock valued at $295,938,000 after purchasing an additional 9,194 shares during the last quarter. World Investment Advisors LLC acquired a new position in Intuitive Surgical during the 3rd quarter valued at approximately $228,000. Nordea Investment Management AB raised its holdings in shares of Intuitive Surgical by 31.7% in the fourth quarter. Nordea Investment Management AB now owns 43,200 shares of the medical equipment provider’s stock worth $22,632,000 after buying an additional 10,405 shares during the last quarter. Capital Market Strategies LLC lifted its stake in shares of Intuitive Surgical by 7.8% during the fourth quarter. Capital Market Strategies LLC now owns 1,237 shares of the medical equipment provider’s stock worth $646,000 after buying an additional 90 shares during the period. Finally, Diversified Trust Co lifted its stake in shares of Intuitive Surgical by 0.6% during the fourth quarter. Diversified Trust Co now owns 4,383 shares of the medical equipment provider’s stock worth $2,288,000 after buying an additional 25 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Intuitive Surgical news, VP Fredrik Widman sold 810 shares of the business’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the sale, the vice president now directly owns 473 shares in the company, valued at approximately $271,397.94. The trade was a 63.13 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Mark Brosius sold 492 shares of the stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $282,299.76. Following the completion of the transaction, the senior vice president now directly owns 4,056 shares of the company’s stock, valued at approximately $2,327,251.68. This represents a 10.82 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 33,313 shares of company stock worth $17,229,143. Company insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. Evercore ISI reduced their target price on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating for the company in a research note on Wednesday, April 23rd. UBS Group raised their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. Royal Bank of Canada dropped their target price on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Jefferies Financial Group raised their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Finally, Robert W. Baird dropped their price objective on shares of Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating on the stock in a report on Wednesday, April 23rd. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $598.95.

Intuitive Surgical Stock Up 0.5 %

Shares of Intuitive Surgical stock opened at $531.82 on Tuesday. The firm has a market cap of $190.61 billion, a PE ratio of 82.97, a P/E/G ratio of 5.85 and a beta of 1.70. The business has a 50-day moving average price of $503.33 and a 200 day moving average price of $534.46. Intuitive Surgical, Inc. has a twelve month low of $379.67 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. During the same period in the prior year, the company posted $1.50 EPS. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.